Effetti del consumo di cannabis fumata sugli adolescenti in età scolare
ISSUP Chile ha presentato un webinar su "Effetti dell'uso di cannabis fumata negli adolescenti delle scuole".
Cerca
Reducing stigma towards people living with HIV and people who inject drugs
Despite extensive evidence regarding the negative effects of stigma experienced by people living with HIV (PLHIV) and people who inject drugs within health care settings, comparatively little evidence exists regarding the effectiveness of...
Consumo di sostanze psicoattive in campioni della popolazione scolastica guatemalteca
È stata condotta una ricerca composta da 4 lavori di laurea magistrale, con metodologia descrittiva mista, che affrontano i diversi fattori di rischio che causano gli studenti in Guatemala, che cadono in problemi di uso, consumo e abuso di...
Treatment for drug and alcohol misuse should involve families and communities
Alcohol and other drug treatment are generally only provided for individuals, often away from their families. Treatment aims to improve well-being and reduce the harms of substance use and families and communities can play a significant...
Adolescenti e uso di sostanze: cosa possono fare i genitori?
Obiettivo: aiutare gli adulti a gestire i rischi relativi all'uso di sostanze da parte degli adolescenti in linea con i principi di prevenzione basati sull'evidenza.
Il fumo e il consumo di alcol tra gli studenti di 15-16 anni stanno...
Comprendere i rischi della miscelazione di droghe
17 febbraio 2022
La miscelazione di droghe, nota anche come uso di polisostanze, si verifica quando due o più farmaci vengono assunti insieme o entro un breve periodo di tempo, intenzionalmente o meno. Anche se qualcuno ha mescolato droghe...
Polysubstance Use Facts
What is polysubstance use?
The use of more than one drug, also known as polysubstance use, is common. This includes when two or more are taken together or within a short time period, either intentionally or unintentionally.
Intentional...
FDA Approves New Buprenorphine Treatment Option for Opioid Use Disorder
For Immediate Release: May 23, 2023
Today, the U.S. Food and Drug Administration approved Brixadi (buprenorphine) extended-release injection for subcutaneous use (under the skin) to treat moderate to severe opioid use disorder (OUD)...
Substance use disorders: a comprehensive update of classification, epidemiology, neurobiology, clinical aspects, treatment and prevention
Abstract
Substance use disorders (SUDs) are highly prevalent and impact individuals' health, well-being, and social functioning. Long-lasting changes in brain networks involved in reward, executive function, stress reactivity, mood, and...
Strategies to Address Cocaine and Methamphetamine
Presented by Richard Rawson, PhD, Emeritus Professor in the Department of Psychiatry and Biobehavioral Science, UCLA School of Medicine and a Research Professor at the University of Vermont, this presentation provided an overview of the...
UNODC supported delegations from four Central Asian countries in a high-level study tour to the United Kingdom
The UNODC Regional Office for Central Asia (ROCA) together with the UNODC Prevention, Treatment and Rehabilitation Section (PTRS) organized a study tour for high-level representatives, including senior officials, policymakers and substance...
72º Regular Session of the Inter-American Drug Abuse Control Comission was held
In the magazine CIJ Informa, the participation of CIJ, host chapter institution of ISSUP Mexico, in the 71st Regular Session of CICAD is reviewed.
The Anti-Stigma Network
The Anti-Stigma Network has been launched!
The Mission
The Anti-Stigma Network has been created by a group of organisations coming together with a shared mission.
Collectively they aim to improve understanding of the stigma and...
Buprenorphine versus methadone for the treatment of opioid dependence
Summary
Background
Opioid dependence is associated with substantial health and social burdens, and opioid agonist treatment (OAT) is highly effective in improving multiple outcomes for people who receive this treatment. Methadone and...
Economic Evaluations of Pharmacologic Treatment for Opioid Use Disorder: A Systematic Literature Review
Abstract
Objective
The crisis of opioid use puts a strain on resources in the United States and worldwide. There are 3 US Food and Drug Administration–approved medications for treatment of opioid use disorder: methadone, buprenorphine...
Comparison of Treatments for Cocaine Use Disorder Among Adults
Key Points
Question What treatments for cocaine use disorder are associated with objective reductions in cocaine use among adults?
Findings In this meta-analysis of 157 clinical trials comprising 402 treatment groups and 15 842...
Cocaine Reading List
Cocaine is an addictive stimulant drug that originates from the leaves of the coca plant, which is indigenous to South America. The drug's effects include heightened alertness, attention, and energy, as well as feelings of euphoria and...
Esaidrocannabinolo (HHC) e sostanze correlate
Introduzione
I mercati dell'esaidrocannabinolo (HHC) e dei cannabinoidi semi-sintetici correlati (SSC) sono aree in rapida evoluzione con informazioni relativamente limitate attualmente disponibili.
La situazione europea presentata nella...
Risposta all'uso di stimolanti: sviluppi nel trattamento
Obiettivo: Comprendere meglio gli attuali sviluppi nel trattamento dell'uso di stimolanti.
Le droghe stimolanti sono seconde solo alla cannabis come classe di droghe illecite più utilizzate a livello globale, rappresentando 68 milioni...
Esplorare le barriere terapeutiche sull'uso di metanfetamina in cristalli tra i giovani in Zimbabwe
L'abuso di sostanze tra i giovani è una delle maggiori preoccupazioni pubbliche nella salute globale. Questo studio si proponeva di esplorare le barriere terapeutiche tra i giovani in Zimbabwe.
I dati sono stati raccolti attraverso...
